ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens

    • 1Broad Institute of Harvard and M.I.T., Cambridge, Massachusetts 02142, USA;
    • 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
    • 3Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
    • 4Program in Biophysics, Harvard University, Boston, Massachusetts 02115, USA;
    • 5Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    • 6 These authors contributed equally to this work.
    • Present addresses: 7Blueprint Medicines, Cambridge, MA 02142, USA;
    • 8 Sage Bionetworks, Seattle, WA 98109, USA.
    • 9 Corresponding authors E-mail [email protected] E-mail [email protected]
Published December 26, 2012. Vol 23 Issue 4, pp. 665-678. https://doi.org/10.1101/gr.143586.112
Download PDF Please log-in to or register for your personal account in order to access PDF Cite Article Permissions Share
cover of Genome Research Vol 36 Issue 5
Current Issue:

Abstract

Genome-scale RNAi libraries enable the systematic interrogation of gene function. However, the interpretation of RNAi screens is complicated by the observation that RNAi reagents designed to suppress the mRNA transcripts of the same gene often produce a spectrum of phenotypic outcomes due to differential on-target gene suppression or perturbation of off-target transcripts. Here we present a computational method, Analytic Technique for Assessment of RNAi by Similarity (ATARiS), that takes advantage of patterns in RNAi data across multiple samples in order to enrich for RNAi reagents whose phenotypic effects relate to suppression of their intended targets. By summarizing only such reagent effects for each gene, ATARiS produces quantitative, gene-level phenotype values, which provide an intuitive measure of the effect of gene suppression in each sample. This method is robust for data sets that contain as few as 10 samples and can be used to analyze screens of any number of targeted genes. We used this analytic approach to interrogate RNAi data derived from screening more than 100 human cancer cell lines and identified HNF1B as a transforming oncogene required for the survival of cancer cells that harbor HNF1B amplifications. ATARiS is publicly available at http://broadinstitute.org/ataris.

Loading
Loading
Back to top